Drugs / LY2393910
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01253278 | Mar 2010 → May 2011 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY2393910 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01253278 ↗ |
| Route | Oral | “administered orally” NCT01253278 ↗ |